Valuation Getinge AB OTC Markets
Stocks
GNGBY
US37427X1046
Medical Equipment, Supplies & Distribution
|
Delayed
OTC Markets
15:57:26 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 24.43 USD | +1.41% |
|
-3.07% | +3.30% |
| 08:05am | Getinge AB Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM | |
| 09-14 | Lannebo Räntefond Kompass rose 0.1% in August, shorter duration limited losses | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 64,824 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 8.78% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 73,025 | 70,782 | 68,281 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 5.17% | -3.07% | -3.53% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 20.5x | 18.4x | 16.3x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2.02x | 1.9x | 1.76x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.7x | 1.2x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.84x | 1.74x | 1.66x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.07x | 1.9x | 1.75x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.2x | 9.23x | 8.2x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 14.2x | 12.8x | 11.2x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.4x | 17.6x | 15.4x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.43% | 5.67% | 6.5% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.174 | 5.612 | 6.011 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.17% | 2.36% | 2.53% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.63 | 12.92 | 14.61 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.5% | 43.4% | 41.2% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,261 | 37,238 | 39,053 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,168 | 7,666 | 8,327 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,146 | 5,550 | 6,116 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,166 | 3,527 | 3,986 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,201 | 5,958 | 3,458 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 238.00 | 238.00 | 238.00 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 | 2/1/23 | 2/1/24 | 1/28/25 | 1/27/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 72.53x | 7.63x | 44.49x | -.--% | 12.6B | |
| 20.47x | 2.07x | 10.19x | 2.17% | 6.64B | |
| 36.52x | 1.71x | 10.7x | -.--% | 6.18B | |
| 27.41x | 5.65x | 15.29x | 1.39% | 5.58B | |
| 34.22x | 10.13x | 25.6x | 0.59% | 5.15B | |
| 17.35x | 2.89x | 15.04x | 3.59% | 3.78B | |
| -12.97x | 2.46x | -22.37x | - | 1.89B | |
| -18.13x | 438.5x | -78.03x | -.--% | 1.77B | |
| 18.44x | 2.26x | 8.86x | 2.07% | 1.59B | |
| Average | 21.76x | 52.59x | 3.31x | 1.23% | 5.02B | |
| Weighted average by Cap. | 36.37x | 22.12x | 17.75x | 0.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GNGBY Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
